NEW YORK, June 12 – Affymetrix stock was down $14.10, or 34 percent, at $26.85 in afternoon trading on Tuesday, following an announcement on Monday after the close of trading that the company was slashing its second quarter revenue expectations.

The company said its revenues for the quarter would total between $44 million and $50 million, a drop of between $6 million and $14 million from previous estimates.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.